Skip to main content
. 2020 Dec 24;14(9):2064–2074. doi: 10.1093/ckj/sfaa260

Table 2.

Clinical, biochemical and organizational factors associated with lack of information concerning home dialysis modalities

Factor Number (%) OR (95% CI)
Patients 106 (6.7)
Diabetic nephropathy No 90 (7.7)
Yes 16 (4.1) 0.53 (0.31–0.91)a
Comorbidity
 DM No 78 (7.7)
Yes 28 (5.2) 0.66 (0.42–1.03)0.06
 Cancer No 80 (6.1)
Yes 26 (10.1) 1.70 (1.07–2.70)a
 Comorbidity number 0 54 (8.0) 1.00 (Referent)
 Subgroups 1 23 (4.9) 0.59 (0.36–0.98)a
>1 29 (6.6) 0.82 (0.51–1.31)
Pre-dialysis course
 Late referral (<3 months) No 42 (3.6)
Yes 55 (18.4) 5.75 (3.77–8.79)c,C
 Suboptimal DI No 15 (1.6)
Yes 91 (14.2) 9.63 (5.52–16.8)c,C

 eGFR decrease 3–0 months prior to

dialysis (mL/min/1.73 m2/month)

<1

>1

10 (1.5)

47 (9.1)

6.70 (3.35–13.8)c

Biochemistry
 eGFR (mL/min/1.73 m2) ≥7 32 (4.5)
<7 73 (8.8) 2.04 (1.33–3.14)c
 Albumin (g/L) <30 45 (9.4) 2.37 (1.39–4.05)b
30–34.9 24 (6.0) 1.47 (0.80–2.68)
≥35 21 (4.1)b 1.00 (Referent)
 CRP (mg/L) <50 67 (6.0)
≥50 36 (11.8) 2.04 (1.33–3.13)c
Initial dialysis
 Dialysis cause Clinical 44 (4.7)
Biochemical 59 (10.2)c 2.31 (1.54–3.47)c
 Life-threatening cause Not primary 75 (6.1)
Primary 29 (9.9)a 1.66 (1.06–2.58)a
Hospital
 University hospital No 5 (1.9)
Yes 101 (7.8)c 4.32 (1.74–10.7)b,B
 Home dialysis first policy No 45 (13.4)
Yes 61 (4.9) 0.33 (0.22.0.50)c,C
 Physician age <50 43 (9.0)
≥50 22 (4.8) 0.51 (0.30–0.87)a
 Nephrologist vintage <10 18 (4.5)
≥10 47 (8.8) 2.03 (1.16–3.55)a

Univariate analysis: aP < 0.05, bP < 0.01, cP < 0.001. Multivariable analysis: AP < 0.05, BP < 0.01, CP < 0.001. Only variables significant in the univariate analysis were included in the multivariable analysis. Comparison to all other patients. Significant factors only. Bold type: independent significant factors on multivariable analysis.